Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileLaura Mauri, M.D.

TitleProfessor of Medicine
InstitutionBrigham and Women's Hospital
DepartmentMedicine
AddressBrigham and Women's Hospital
General Medicine - Clinical Biometrics
1620 Tremont St
Boston MA 02120
Phone617/732-7139
Fax617/732-7752
vCardDownload vCard (login for email)

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Secemsky EA, Kirtane A, Bangalore S, Jovin IS, Patel D, Ferro EG, Wimmer NJ, Roe M, Dai D, Mauri L, Yeh RW. Practice Patterns and In-Hospital Outcomes Associated With Bivalirudin Use Among Patients With Non-ST-Segment-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention in the United States. Circ Cardiovasc Qual Outcomes. 2017 Sep; 10(9). PMID: 28855222.
    View in: PubMed
  2. Kandzari DE, Mauri L, Koolen JJ, Massaro JM, Doros G, Garcia-Garcia HM, Bennett J, Roguin A, Gharib EG, Cutlip DE, Waksman R. Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial. Lancet. 2017 Aug 25. PMID: 28851504.
    View in: PubMed
  3. Cuisset T, Verheugt FWA, Mauri L. Update on antithrombotic therapy after percutaneous coronary revascularisation. Lancet. 2017 Aug 19; 390(10096):810-820. PMID: 28831996.
    View in: PubMed
  4. Mangione FM, Jatene T, Badr Eslam R, Bergmark BA, Gallagher JR, Shah PB, Mauri L, Leopold JA, Sobieszczyk PS, Faxon DP, Croce KJ, Bhatt DL, Devlin PM. Usefulness of Intracoronary Brachytherapy for Patients With Resistant Drug-Eluting Stent Restenosis. Am J Cardiol. 2017 Aug 01; 120(3):369-373. PMID: 28583681.
    View in: PubMed
  5. Secemsky EA, Yeh RW, Kereiakes DJ, Cutlip DE, Cohen DJ, Steg PG, Cannon CP, Apruzzese PK, D'Agostino RB, Massaro JM, Mauri L. Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study. JAMA Cardiol. 2017 May 01; 2(5):478-487. PMID: 28297015.
    View in: PubMed
  6. Resor CD, Mauri L. Response by Resor and Mauri to Letter Regarding Article, "Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study". Circulation. 2017 Apr 04; 135(14):e866. PMID: 28373533.
    View in: PubMed
  7. Roguin A, Camenzind E, Kerner A, Beyar R, Boersma E, Mauri L, Steg PG, Wijns W. Long-Term Outcomes of Stenting the Proximal Left Anterior Descending Artery in the PROTECT Trial. JACC Cardiovasc Interv. 2017 Mar 27; 10(6):548-556. PMID: 28335893.
    View in: PubMed
  8. Perruzza L, Gargari G, Proietti M, Fosso B, D'Erchia AM, Faliti CE, Rezzonico-Jost T, Scribano D, Mauri L, Colombo D, Pellegrini G, Moregola A, Mooser C, Pesole G, Nicoletti M, Norata GD, Geuking MB, McCoy KD, Guglielmetti S, Grassi F. T Follicular Helper Cells Promote a Beneficial Gut Ecosystem for Host Metabolic Homeostasis by Sensing Microbiota-Derived Extracellular ATP. Cell Rep. 2017 Mar 14; 18(11):2566-2575. PMID: 28297661.
    View in: PubMed
  9. Go S, Go S, Veillon L, Ciampa MG, Mauri L, Sato C, Kitajima K, Prinetti A, Sonnino S, Inokuchi JI. Altered expression of ganglioside GM3 molecular species and a potential regulatory role during myoblast differentiation. J Biol Chem. 2017 Apr 28; 292(17):7040-7051. PMID: 28275055.
    View in: PubMed
  10. Stefanescu Schmidt AC, Kereiakes DJ, Cutlip DE, Yeh RW, D'Agostino RB, Massaro JM, Hsieh WH, Mauri L. Myocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy). Circulation. 2017 May 02; 135(18):1720-1732. PMID: 28228427.
    View in: PubMed
  11. Yeh RW, Silber S, Chen L, Chen S, Hiremath S, Neumann FJ, Qiao S, Saito S, Xu B, Yang Y, Mauri L. 5-Year Safety and Efficacy of Resolute Zotarolimus-Eluting Stent: The RESOLUTE Global Clinical Trial Program. JACC Cardiovasc Interv. 2017 Feb 13; 10(3):247-254. PMID: 28109872.
    View in: PubMed
  12. Vaduganathan M, Qamar A, Singh A, Venkateswaran RV, Szumita PM, Croce KJ, Mauri L, Leopold JA, Shah PB, Sobieszczyk P, Faxon DP, Bhatt DL. Cangrelor Use Since FDA Approval: A Single-Center, Real-World Experience at a Tertiary Care Hospital. J Am Coll Cardiol. 2017 Jan 31; 69(4):463-464. PMID: 27914699.
    View in: PubMed
  13. Secemsky EA, Kirtane A, Bangalore S, Jovin IS, Shah RM, Ferro EG, Wimmer NJ, Roe M, Dai D, Mauri L, Yeh RW. Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United States. JACC Cardiovasc Interv. 2016 Dec 12; 9(23):2376-2386. PMID: 27838271.
    View in: PubMed
  14. Angiolillo DJ, Goodman SG, Bhatt DL, Eikelboom JW, Price MJ, Moliterno DJ, Cannon CP, Tanguay JF, Granger CB, Mauri L, Holmes DR, Gibson CM, Faxon DP. Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update. Circ Cardiovasc Interv. 2016 Nov; 9(11). PMID: 27803042.
    View in: PubMed
  15. Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, Granger CB, Lange RA, Mack MJ, Mauri L, Mehran R, Mukherjee D, Newby LK, O'Gara PT, Sabatine MS, Smith PK, Smith SC, Halperin JL, Levine GN, Al-Khatib SM, Birtcher KK, Bozkurt B, Brindis RG, Cigarroa JE, Curtis LH, Fleisher LA, Gentile F, Gidding S, Hlatky MA, Ikonomidis JS, Joglar JA, Pressler SJ, Wijeysundera DN. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2016 Nov; 152(5):1243-1275. PMID: 27751237.
    View in: PubMed
  16. Nakayama H, Kurihara H, Morita YS, Kinoshita T, Mauri L, Prinetti A, Sonnino S, Yokoyama N, Ogawa H, Takamori K, Iwabuchi K. Lipoarabinomannan binding to lactosylceramide in lipid rafts is essential for the phagocytosis of mycobacteria by human neutrophils. Sci Signal. 2016 Oct 11; 9(449):ra101. PMID: 27729551.
    View in: PubMed
  17. Federspiel JJ, Anstrom KJ, Xian Y, McCoy LA, Effron MB, Faries DE, Zettler M, Mauri L, Yeh RW, Peterson ED, Wang TY. Comparing Inverse Probability of Treatment Weighting and Instrumental Variable Methods for the Evaluation of Adenosine Diphosphate Receptor Inhibitors After Percutaneous Coronary Intervention. JAMA Cardiol. 2016 Sep 01; 1(6):655-65. PMID: 27438179.
    View in: PubMed
  18. Mauri L, Smith SC. Focused Update on Duration of Dual Antiplatelet Therapy for Patients With Coronary Artery Disease. JAMA Cardiol. 2016 Sep 01; 1(6):733-4. PMID: 27548911.
    View in: PubMed
  19. Bonaca MP, Goto S, Bhatt DL, Steg PG, Storey RF, Cohen M, Goodrich E, Mauri L, Ophuis TO, Ruda M, Špinar J, Seung KB, Hu D, Dalby AJ, Jensen E, Held P, Morrow DA, Braunwald E, Sabatine MS. Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54). Circulation. 2016 Sep 20; 134(12):861-71. PMID: 27576775.
    View in: PubMed
  20. Resor CD, Nathan A, Kereiakes DJ, Yeh RW, Massaro JM, Cutlip DE, Gabriel Steg P, Hsieh WH, Mauri L. Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study. Circulation. 2016 Oct 04; 134(14):989-998. PMID: 27576774.
    View in: PubMed
  21. Patel MR, Armstrong PW, Bhatt DL, Braunwald E, Camm AJ, Fox KA, Harrington RA, Hiatt WR, James SK, Kirtane AJ, Leon MB, Lincoff AM, Mahaffey KW, Mauri L, Mehran R, Mehta SR, Montalescot G, Nicholls SJ, Perkovic V, Peterson ED, Pocock SJ, Roe MT, Sabatine MS, Sekeres M, Solomon SD, Steg G, Stone GW, Van de Werf F, Wallentin L, White HD, Gibson M. Sharing Data from Cardiovascular Clinical Trials--A Proposal. N Engl J Med. 2016 Aug 04; 375(5):407-9. PMID: 27518659.
    View in: PubMed
  22. Ten Haaf M, Appelman Y, Wijns W, Steg G, Mauri L, Rademaker-Havinga T, Wetzels G, Bousquette L, Camenzind E, Boersma E. Frequency of Stent Thrombosis Risk at 5 Years in Women Versus Men With Zotarolimus-Eluting Compared With Sirolimus-Eluting Stent. Am J Cardiol. 2016 Oct 15; 118(8):1178-1186. PMID: 27569387.
    View in: PubMed
  23. Abdel-Wahab M, Neumann FJ, Serruys P, Silber S, Leon M, Mauri L, Yeung A, Belardi JA, Widimský P, Meredith I, Saito S, Richardt G. Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program. EuroIntervention. 2016 Jul 20; 12(4):465-72. PMID: 26477642.
    View in: PubMed
  24. Feldman T, Komtebedde J, Burkhoff D, Massaro J, Maurer MS, Leon MB, Kaye D, Silvestry FE, Cleland JG, Kitzman D, Kubo SH, Van Veldhuisen DJ, Kleber F, Trochu JN, Auricchio A, Gustafsson F, Hasenfuß G, Ponikowski P, Filippatos G, Mauri L, Shah SJ. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure: Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I). Circ Heart Fail. 2016 Jul; 9(7). PMID: 27330010.
    View in: PubMed
  25. Carreras ET, Chatzizisis YS, Mauri L, MacRae C. Acute Coronary Syndrome in a 52-Year-Old Woman With Scleroderma. Circulation. 2016 Jun 14; 133(24):2576-82. PMID: 27297349.
    View in: PubMed
  26. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Ting HH, O'Gara PT, Kushner FG, Ascheim DD, Brindis RG, Casey DE, Chung MK, de Lemos JA, Diercks DB, Fang JC, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Kristin Newby L, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Joseph Woo Y, Zhao DX, Halperin JL, Levine GN, Anderson JL, Albert NM, Al-Khatib SM, Birtcher KK, Bozkurt B, Brindis RG, Cigarroa JE, Curtis LH, Fleisher LA, Gentile F, Gidding S, Hlatky MA, Ikonomidis J, Joglar J, Kovacs RJ, Magnus Ohman E, Pressler SJ, Sellke FW, Shen WK, Wijeysundera DN. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial Infarction: An update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2016 May; 87(6):1001-19. PMID: 26489034.
    View in: PubMed
  27. Yeh RW, Secemsky EA, Kereiakes DJ, Normand SL, Gershlick AH, Cohen DJ, Spertus JA, Steg PG, Cutlip DE, Rinaldi MJ, Camenzind E, Wijns W, Apruzzese PK, Song Y, Massaro JM, Mauri L. Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention. JAMA. 2016 Apr 26; 315(16):1735-49. PMID: 27022822.
    View in: PubMed
  28. Kereiakes DJ, Yeh RW, Massaro JM, Cutlip DE, Steg PG, Wiviott SD, Mauri L. DAPT Score Utility for Risk Prediction in Patients With or Without Previous Myocardial Infarction. J Am Coll Cardiol. 2016 May 31; 67(21):2492-502. PMID: 27046159.
    View in: PubMed
  29. Wimmer NJ, Secemsky EA, Mauri L, Roe MT, Saha-Chaudhuri P, Dai D, McCabe JM, Resnic FS, Gurm HS, Yeh RW. Effectiveness of Arterial Closure Devices for Preventing Complications With Percutaneous Coronary Intervention: An Instrumental Variable Analysis. Circ Cardiovasc Interv. 2016 Apr; 9(4):e003464. PMID: 27059685; PMCID: PMC4832135 [Available on 04/01/17].
  30. Mauri L, O'Gara PT. Predicting Outcomes in Individual Patients After Transcatheter Aortic Valve Replacement: Small Steps on the Path to Improved Decision Making. JAMA Cardiol. 2016 Apr 01; 1(1):53-4. PMID: 27437654.
    View in: PubMed
  31. Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, Granger CB, Lange RA, Mack MJ, Mauri L, Mehran R, Mukherjee D, Newby LK, O'Gara PT, Sabatine MS, Smith PK, Smith SC. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016 Sep 06; 68(10):1082-115. PMID: 27036918.
    View in: PubMed
  32. Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, Granger CB, Lange RA, Mack MJ, Mauri L, Mehran R, Mukherjee D, Newby LK, O'Gara PT, Sabatine MS, Smith PK, Smith SC. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. Circulation. 2016 Sep 06; 134(10):e123-55. PMID: 27026020.
    View in: PubMed
  33. Meredith IT, Tanguay JF, Kereiakes DJ, Cutlip DE, Yeh RW, Garratt KN, Lee DP, Steg PG, Weaver WD, Holmes DR, Brindis RG, Trebacz J, Massaro JM, Hsieh WH, Mauri L. Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy Study. Circulation. 2016 May 03; 133(18):1772-82. PMID: 26994121.
    View in: PubMed
  34. Vora AN, Dai D, Gurm H, Amin AP, Messenger JC, Mahmud E, Mauri L, Wang TY, Roe MT, Curtis J, Patel MR, Dauerman HL, Peterson ED, Rao SV. Temporal Trends in the Risk Profile of Patients Undergoing Outpatient Percutaneous Coronary Intervention: A Report from the National Cardiovascular Data Registry's CathPCI Registry. Circ Cardiovasc Interv. 2016 Mar; 9(3):e003070. PMID: 26957417.
    View in: PubMed
  35. Sonnino S, Chiricozzi E, Ciampa MG, Mauri L, Prinetti A, Toffano G, Aureli M. Serum Antibodies to Glycans in Peripheral Neuropathies. Mol Neurobiol. 2017 Mar; 54(2):1564-1567. PMID: 26867654.
    View in: PubMed
  36. Hermiller JB, Krucoff MW, Kereiakes DJ, Windecker S, Steg PG, Yeh RW, Cohen DJ, Cutlip DE, Massaro JM, Hsieh WH, Mauri L. Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents. JACC Cardiovasc Interv. 2016 Jan 25; 9(2):138-47. PMID: 26793956.
    View in: PubMed
  37. Wayangankar SA, Bangalore S, McCoy LA, Jneid H, Latif F, Karrowni W, Charitakis K, Feldman DN, Dakik HA, Mauri L, Peterson ED, Messenger J, Roe M, Mukherjee D, Klein A. Temporal Trends and Outcomes of Patients Undergoing Percutaneous Coronary Interventions for Cardiogenic Shock in the Setting of Acute Myocardial Infarction: A Report From the CathPCI Registry. JACC Cardiovasc Interv. 2016 Feb 22; 9(4):341-351. PMID: 26803418.
    View in: PubMed
  38. Feldman T, Kar S, Elmariah S, Smart SC, Trento A, Siegel RJ, Apruzzese P, Fail P, Rinaldi MJ, Smalling RW, Hermiller JB, Heimansohn D, Gray WA, Grayburn PA, Mack MJ, Lim DS, Ailawadi G, Herrmann HC, Acker MA, Silvestry FE, Foster E, Wang A, Glower DD, Mauri L. Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST II. J Am Coll Cardiol. 2015 Dec 29; 66(25):2844-54. PMID: 26718672.
    View in: PubMed
  39. Wimmer NJ, Mauri L. Renal Denervation: Where to Now? Curr Cardiol Rep. 2015 Dec; 17(12):116. PMID: 26482759.
    View in: PubMed
  40. Mauri L, Elmariah S, Yeh RW, Cutlip DE, Steg PG, Windecker S, Wiviott SD, Cohen DJ, Massaro JM, D'Agostino RB, Braunwald E, Kereiakes DJ. Causes of late mortality with dual antiplatelet therapy after coronary stents. Eur Heart J. 2016 Jan 21; 37(4):378-85. PMID: 26586780; PMCID: PMC4751218 [Available on 01/21/17].
  41. Yeh RW, Kereiakes DJ, Mauri L. Reply: Analysis of Dual Antiplatelet Therapy. J Am Coll Cardiol. 2015 Nov 03; 66(18):2056. PMID: 26516012.
    View in: PubMed
  42. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Ting HH, O'Gara PT, Kushner FG, Ascheim DD, Brindis RG, Casey DE, Chung MK, de Lemos JA, Diercks DB, Fang JC, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX. 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. J Am Coll Cardiol. 2016 Mar 15; 67(10):1235-50. PMID: 26498666.
    View in: PubMed
  43. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Ting HH, O'Gara PT, Kushner FG, Ascheim DD, Brindis RG, Casey DE, Chung MK, de Lemos JA, Diercks DB, Fang JC, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX. 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2016 Mar 15; 133(11):1135-47. PMID: 26490017.
    View in: PubMed
  44. Yeh RW, Elmariah S, Doros G, Kereiakes DJ, Mauri L. Mortality risk with dual antiplatelet therapy? Lancet. 2015 Oct 17; 386(10003):1533-4. PMID: 26530618; PMCID: PMC4671290 [Available on 10/17/16].
  45. Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon DI, Iancu AC, Trebacz J, Mauri L. Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy. JACC Cardiovasc Interv. 2015 Oct; 8(12):1552-62. PMID: 26493248.
    View in: PubMed
  46. Garratt KN, Weaver WD, Jenkins RG, Pow TK, Mauri L, Kereiakes DJ, Winters KJ, Christen T, Allocco DJ, Lee DP. Response to letters regarding article, "prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement". Circulation. 2015 Sep 29; 132(13):e166-7. PMID: 26416639.
    View in: PubMed
  47. Yeh RW, Kereiakes DJ, Mauri L. Reply: Impact of Clinical Presentation on Dual Antiplatelet Therapy Duration: Let's Re-Evaluate Our Priorities. J Am Coll Cardiol. 2015 Sep 08; 66(10):1204-5. PMID: 26338005.
    View in: PubMed
  48. Udell JA, Bonaca MP, Collet JP, Lincoff AM, Kereiakes DJ, Costa F, Lee CW, Mauri L, Valgimigli M, Park SJ, Montalescot G, Sabatine MS, Braunwald E, Bhatt DL. Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials. Eur Heart J. 2016 Jan 21; 37(4):390-9. PMID: 26324537.
    View in: PubMed
  49. Wasfy JH, Singal G, O'Brien C, Blumenthal DM, Kennedy KF, Strom JB, Spertus JA, Mauri L, Normand SL, Yeh RW. Enhancing the Prediction of 30-Day Readmission After Percutaneous Coronary Intervention Using Data Extracted by Querying of the Electronic Health Record. Circ Cardiovasc Qual Outcomes. 2015 Sep; 8(5):477-85. PMID: 26286871.
    View in: PubMed
  50. Wang TY, Grines C, Ortega R, Dai D, Jacobs AK, Skelding KA, Mauri L, Mehran R. Women in interventional cardiology: Update in percutaneous coronary intervention practice patterns and outcomes of female operators from the National Cardiovascular Data Registry®. Catheter Cardiovasc Interv. 2016 Mar; 87(4):663-8. PMID: 26255880.
    View in: PubMed
  51. Flack JM, Bhatt DL, Kandzari DE, Brown D, Brar S, Choi JW, D'Agostino R, East C, Katzen BT, Lee L, Leon MB, Mauri L, O'Neill WW, Oparil S, Rocha-Singh K, Townsend RR, Bakris G. An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial. J Am Soc Hypertens. 2015 Oct; 9(10):769-79. PMID: 26362830.
    View in: PubMed
  52. Weber MA, Kirtane A, Mauri L, Townsend RR, Kandzari DE, Leon MB. Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It Right. Clin Cardiol. 2015 Aug; 38(8):447-54. PMID: 26216107.
    View in: PubMed
  53. Weber MA, Kirtane A, Mauri L, Townsend RR, Kandzari DE, Leon MB. Renal denervation for the treatment of hypertension: Making a new start, getting it right. Catheter Cardiovasc Interv. 2015 Nov; 86(5):855-63. PMID: 26097069.
    View in: PubMed
  54. Matteau A, Yeh RW, Camenzind E, Steg PG, Wijns W, Mills J, Gershlick A, de Belder M, Ducrocq G, Mauri L. Balancing Long-Term Risks of Ischemic and Bleeding Complications After Percutaneous Coronary Intervention With Drug-Eluting Stents. Am J Cardiol. 2015 Sep 01; 116(5):686-93. PMID: 26187674; PMCID: PMC4670082.
  55. Yeh RW, Elmariah S, Doros G, Kereiakes DJ, Mauri L. Dual antiplatelet therapy duration and mortality - Authors' reply. Lancet. 2015 May 30; 385(9983):2149-50. PMID: 26068262.
    View in: PubMed
  56. Wang ZJ, Zhou YJ, Galper BZ, Gao F, Yeh RW, Mauri L. Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysis. Heart. 2015 Oct; 101(20):1631-8. PMID: 26025084.
    View in: PubMed
  57. Weber MA, Kirtane A, Mauri L, Townsend RR, Kandzari DE, Leon MB. Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It Right. J Clin Hypertens (Greenwich). 2015 Oct; 17(10):743-50. PMID: 25973584.
    View in: PubMed
  58. Pasutto F, Mauri L, Popp B, Sticht H, Ekici A, Piozzi E, Bonfante A, Penco S, Schlötzer-Schrehardt U, Reis A. Whole exome sequencing reveals a novel de novo FOXC1 mutation in a patient with unrecognized Axenfeld-Rieger syndrome and glaucoma. Gene. 2015 Aug 15; 568(1):76-80. PMID: 25967385.
    View in: PubMed
  59. White WB, Galis ZS, Henegar J, Kandzari DE, Victor R, Sica D, Townsend RR, Turner JR, Virmani R, Mauri L. Renal denervation therapy for hypertension: pathways for moving development forward. J Am Soc Hypertens. 2015 May; 9(5):341-50. PMID: 25979410.
    View in: PubMed
  60. Garcia L, Jaff MR, Metzger C, Sedillo G, Pershad A, Zidar F, Patlola R, Wilkins RG, Espinoza A, Iskander A, Khammar GS, Khatib Y, Beasley R, Makam S, Kovach R, Kamat S, Leon LR, Eaves WB, Popma JJ, Mauri L, Donohoe D, Base CC, Rosenfield K. Wire-Interwoven Nitinol Stent Outcome in the Superficial Femoral and Proximal Popliteal Arteries: Twelve-Month Results of the SUPERB Trial. Circ Cardiovasc Interv. 2015 May; 8(5). PMID: 25969545.
    View in: PubMed
  61. Bakris GL, Townsend RR, Flack JM, Brar S, Cohen SA, D'Agostino R, Kandzari DE, Katzen BT, Leon MB, Mauri L, Negoita M, O'Neill WW, Oparil S, Rocha-Singh K, Bhatt DL. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial. J Am Coll Cardiol. 2015 Apr 07; 65(13):1314-21. PMID: 25835443.
    View in: PubMed
  62. Mauri L, Yeh RW, Kereiakes DJ. Duration of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2015 Apr 02; 372(14):1373-4. PMID: 25830429.
    View in: PubMed
  63. Secemsky EA, Matteau A, Yeh RW, Steg PG, Camenzind E, Wijns W, McFadden E, Mauri L. Comparison of Short- and Long-Term Cardiac Mortality in Early Versus Late Stent Thrombosis (from Pooled PROTECT Trials). Am J Cardiol. 2015 Jun 15; 115(12):1678-84. PMID: 25910523.
    View in: PubMed
  64. Yeh RW, Cohen DJ, Mauri L. Close encounters with errors of the second kind: evaluating risks and benefits of long-term dual antiplatelet therapy. Eur Heart J. 2015 May 21; 36(20):1216-8. PMID: 25796054.
    View in: PubMed
  65. Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon DI, Iancu AC, Trebacz J, Mauri L. Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial. JAMA. 2015 Mar 17; 313(11):1113-21. PMID: 25781440; PMCID: PMC4481320.
  66. Yeh RW, Kereiakes DJ, Steg PG, Windecker S, Rinaldi MJ, Gershlick AH, Cutlip DE, Cohen DJ, Tanguay JF, Jacobs A, Wiviott SD, Massaro JM, Iancu AC, Mauri L. Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction. J Am Coll Cardiol. 2015 May 26; 65(20):2211-21. PMID: 25787199; PMCID: PMC4678101.
  67. Aureli M, Mauri L, Ciampa MG, Prinetti A, Toffano G, Secchieri C, Sonnino S. GM1 Ganglioside: Past Studies and Future Potential. Mol Neurobiol. 2016 Apr; 53(3):1824-1842. PMID: 25762012.
    View in: PubMed
  68. Yeh RW, Mauri L, Kereiakes DJ. Dual Antiplatelet Therapy Duration Following Coronary Stenting. [Corrected]. J Am Coll Cardiol. 2015 Mar 03; 65(8):787-90. PMID: 25720621; PMCID: PMC4689133.
  69. Yeh RW, Mauri L, Wolf RE, Romm IK, Lovett A, Shahian D, Normand SL. Population trends in rates of coronary revascularization. JAMA Intern Med. 2015 Mar; 175(3):454-6. PMID: 25559059; PMCID: PMC4385321.
  70. Cutlip DE, Kereiakes DJ, Mauri L, Stoler R, Dauerman HL. Thrombotic complications associated with early and late nonadherence to dual antiplatelet therapy. JACC Cardiovasc Interv. 2015 Mar; 8(3):404-410. PMID: 25703885.
    View in: PubMed
  71. Diletti R, Garcia-Garcia HM, Bourantas C, Van Mieghem NM, van Geuns RJ, Muramatsu T, Zhang YJ, Mauri L, Belardi J, Silber S, Widimsky P, Leon M, Windecker S, Meredith I, Neumann FJ, Yeung AC, Saito S, Liu M, van Leeuwen F, Serruys PW. Impact of body mass index on long-term clinical outcomes after second-generation drug eluting stent implantation: Insights from the international global RESOLUTE program. Catheter Cardiovasc Interv. 2015 May; 85(6):952-8. PMID: 25689692.
    View in: PubMed
  72. Sonnino S, Aureli M, Mauri L, Ciampa MG, Prinetti A. Membrane lipid domains in the nervous system. Front Biosci (Landmark Ed). 2015 Jan 01; 20:280-302. PMID: 25553451.
    View in: PubMed
  73. Chiricozzi E, Ciampa MG, Brasile G, Compostella F, Prinetti A, Nakayama H, Ekyalongo RC, Iwabuchi K, Sonnino S, Mauri L. Direct interaction, instrumental for signaling processes, between LacCer and Lyn in the lipid rafts of neutrophil-like cells. J Lipid Res. 2015 Jan; 56(1):129-41. PMID: 25418321; PMCID: PMC4274061.
  74. Garratt KN, Weaver WD, Jenkins RG, Pow TK, Mauri L, Kereiakes DJ, Winters KJ, Christen T, Allocco DJ, Lee DP. Prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement. Circulation. 2015 Jan 06; 131(1):62-73. PMID: 25400062.
    View in: PubMed
  75. Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, Normand SL, Braunwald E, Wiviott SD, Cohen DJ, Holmes DR, Krucoff MW, Hermiller J, Dauerman HL, Simon DI, Kandzari DE, Garratt KN, Lee DP, Pow TK, Ver Lee P, Rinaldi MJ, Massaro JM. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2014 Dec 04; 371(23):2155-66. PMID: 25399658; PMCID: PMC4481318.
  76. Yeh RW, Czarny MJ, Normand SL, Kereiakes DJ, Holmes DR, Brindis RG, Weaver WD, Rumsfeld JS, Roe MT, Kim S, Driscoll-Shempp P, Mauri L. Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data Registry. Circ Cardiovasc Qual Outcomes. 2015 Jan; 8(1):96-102. PMID: 25399847; PMCID: PMC4303486 [Available on 01/01/16].
  77. Kandzari DE, Bhatt DL, Brar S, Devireddy CM, Esler M, Fahy M, Flack JM, Katzen BT, Lea J, Lee DP, Leon MB, Ma A, Massaro J, Mauri L, Oparil S, O'Neill WW, Patel MR, Rocha-Singh K, Sobotka PA, Svetkey L, Townsend RR, Bakris GL. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. Eur Heart J. 2015 Jan 21; 36(4):219-27. PMID: 25400162; PMCID: PMC4301597 [Available on 01/21/16].
  78. Elmariah S, Mauri L, Doros G, Galper BZ, O'Neill KE, Steg PG, Kereiakes DJ, Yeh RW. Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis. Lancet. 2015 Feb 28; 385(9970):792-8. PMID: 25467565; PMCID: PMC4386690.
  79. Garg P, Galper BZ, Cohen DJ, Yeh RW, Mauri L. Balancing the risks of bleeding and stent thrombosis: a decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents. Am Heart J. 2015 Feb; 169(2):222-233.e5. PMID: 25641531; PMCID: PMC4407277.
  80. Mauri L, Galper BZ. Late stent thrombosis: can it be prevented? JACC Cardiovasc Interv. 2014 Oct; 7(10):1103-4. PMID: 25341706.
    View in: PubMed
  81. Wasfy JH, Strom JB, Waldo SW, O'Brien C, Wimmer NJ, Zai AH, Luttrell J, Spertus JA, Kennedy KF, Normand SL, Mauri L, Yeh RW. Clinical preventability of 30-day readmission after percutaneous coronary intervention. J Am Heart Assoc. 2014 Sep 26; 3(5):e001290. PMID: 25261531; PMCID: PMC4323776.
  82. Wijns W, Steg PG, Mauri L, Kurowski V, Parikh K, Gao R, Bode C, Greenwood JP, Lipsic E, Alamgir F, Rademaker-Havinga T, Boersma E, Radke P, van Leeuwen F, Camenzind E. Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4-year results of the PROTECT randomized trial. Eur Heart J. 2014 Oct 21; 35(40):2812-20. PMID: 25106761.
    View in: PubMed
  83. Elmariah S, Furlan AJ, Reisman M, Burke D, Vardi M, Wimmer NJ, Ling S, Chen X, Kent DM, Massaro J, Mauri L. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial. JACC Cardiovasc Interv. 2014 Aug; 7(8):913-20. PMID: 25147037.
    View in: PubMed
  84. Glower DD, Kar S, Trento A, Lim DS, Bajwa T, Quesada R, Whitlow PL, Rinaldi MJ, Grayburn P, Mack MJ, Mauri L, McCarthy PM, Feldman T. Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study. J Am Coll Cardiol. 2014 Jul 15; 64(2):172-81. PMID: 25011722.
    View in: PubMed
  85. Bakris GL, Townsend RR, Liu M, Cohen SA, D'Agostino R, Flack JM, Kandzari DE, Katzen BT, Leon MB, Mauri L, Negoita M, O'Neill WW, Oparil S, Rocha-Singh K, Bhatt DL. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3. J Am Coll Cardiol. 2014 Sep 16; 64(11):1071-8. PMID: 24858423.
    View in: PubMed
  86. Czarny MJ, Nathan AS, Yeh RW, Mauri L. Adherence to dual antiplatelet therapy after coronary stenting: a systematic review. Clin Cardiol. 2014 Aug; 37(8):505-13. PMID: 24797884; PMCID: PMC4140973.
  87. Caputo R, Leon M, Serruys P, Neumann FJ, Yeung A, Windecker S, Belardi JA, Silber S, Meredith I, Widimský P, Saito S, Mauri L. Performance of the resolute zotarolimus-eluting stent in small vessels. Catheter Cardiovasc Interv. 2014 Jul 01; 84(1):17-23. PMID: 24659581.
    View in: PubMed
  88. Wimmer NJ, Cohen DJ, Wasfy JH, Rathore SS, Mauri L, Yeh RW. Delay in reperfusion with transradial percutaneous coronary intervention for ST-elevation myocardial infarction: Might some delays be acceptable? Am Heart J. 2014 Jul; 168(1):103-9. PMID: 24952866; PMCID: PMC4067602.
  89. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014 Apr 10; 370(15):1393-401. PMID: 24678939.
    View in: PubMed
  90. Camenzind E, Boersma E, Wijns W, Mauri L, Rademaker-Havinga T, Ordoubadi FF, Suttorp MJ, Al Kurdi M, Steg PG. Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type. Eur Heart J. 2014 Aug 01; 35(29):1932-48. PMID: 24627416.
    View in: PubMed
  91. Vardi M, Debidda M, Bhatt DL, Mauri L, Cannon CP. Evolving antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: results from a survey among US cardiologists. Clin Cardiol. 2014 Feb; 37(2):103-7. PMID: 24672813.
    View in: PubMed
  92. Vardi M, Novack V, Pencina MJ, Doros G, Burke DA, Elmariah S, Cutlip DE, Mauri L, Yeh RW. Safety and efficacy metrics for primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis and critical examination of current methodologies. Catheter Cardiovasc Interv. 2014 May 01; 83(6):975-83. PMID: 23996913.
    View in: PubMed
  93. Nørgaard BL, Leipsic J, Gaur S, Seneviratne S, Ko BS, Ito H, Jensen JM, Mauri L, De Bruyne B, Bezerra H, Osawa K, Marwan M, Naber C, Erglis A, Park SJ, Christiansen EH, Kaltoft A, Lassen JF, Bøtker HE, Achenbach S. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps). J Am Coll Cardiol. 2014 Apr 01; 63(12):1145-55. PMID: 24486266.
    View in: PubMed
  94. Wasfy JH, Strom JB, O'Brien C, Zai AH, Luttrell J, Kennedy KF, Spertus JA, Zelevinsky K, Normand SL, Mauri L, Yeh RW. Causes of short-term readmission after percutaneous coronary intervention. Circ Cardiovasc Interv. 2014 Feb; 7(1):97-103. PMID: 24425587.
    View in: PubMed
  95. Aureli M, Samarani M, Murdica V, Mauri L, Loberto N, Bassi R, Prinetti A, Sonnino S. Gangliosides and cell surface ganglioside glycohydrolases in the nervous system. Adv Neurobiol. 2014; 9:223-44. PMID: 25151381.
    View in: PubMed
  96. Sonnino S, Aureli M, Grassi S, Mauri L, Prioni S, Prinetti A. Lipid rafts in neurodegeneration and neuroprotection. Mol Neurobiol. 2014 Aug; 50(1):130-48. PMID: 24362851.
    View in: PubMed
  97. Yeh RW, Vasaiwala S, Forman DE, Silbaugh TS, Zelevinski K, Lovett A, Normand SL, Mauri L. Instrumental variable analysis to compare effectiveness of stents in the extremely elderly. Circ Cardiovasc Qual Outcomes. 2014 Jan; 7(1):118-24. PMID: 24254887.
    View in: PubMed
  98. Matteau A, Yeh RW, Kereiakes D, Orav EJ, Massaro J, Steg PG, Normand SL, Cutlip DE, Mauri L. Frequency of the use of low- versus high-dose aspirin in dual antiplatelet therapy after percutaneous coronary intervention (from the Dual Antiplatelet Therapy study). Am J Cardiol. 2014 Apr 01; 113(7):1146-52. PMID: 24332248.
    View in: PubMed
  99. Navarese EP, Tandjung K, Claessen B, Andreotti F, Kowalewski M, Kandzari DE, Kereiakes DJ, Waksman R, Mauri L, Meredith IT, Finn AV, Kim HS, Kubica J, Suryapranata H, Aprami TM, Di Pasquale G, von Birgelen C, Kedhi E. Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis. BMJ. 2013 Nov 06; 347:f6530. PMID: 24196498; PMCID: PMC3819044.
  100. Abizaid A, Ormiston JA, Fajadet J, Mauri L, Schofer J, Verheye S, Dens J, Thuesen L, Macours N, Qureshi AC, Spaulding C. Two-year follow-up of the NEVO ResElution-I(NEVO RES-I) trial: a randomised, multicentre comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions. EuroIntervention. 2013 Oct; 9(6):721-9. PMID: 23518218.
    View in: PubMed
  101. Gaur S, Achenbach S, Leipsic J, Mauri L, Bezerra HG, Jensen JM, Bøtker HE, Lassen JF, Nørgaard BL. Rationale and design of the HeartFlowNXT (HeartFlow analysis of coronary blood flow using CT angiography: NeXt sTeps) study. J Cardiovasc Comput Tomogr. 2013 Sep-Oct; 7(5):279-88. PMID: 24268114.
    View in: PubMed
  102. Grayburn PA, Foster E, Sangli C, Weissman NJ, Massaro J, Glower DG, Feldman T, Mauri L. Relationship between the magnitude of reduction in mitral regurgitation severity and left ventricular and left atrial reverse remodeling after MitraClip therapy. Circulation. 2013 Oct 08; 128(15):1667-74. PMID: 24014834.
    View in: PubMed
  103. Mauri L. Nonculprit lesions--innocent or guilty by association. N Engl J Med. 2013 09 19; 369(12):1166-7. PMID: 23991624.
    View in: PubMed
  104. Belardi JA, Widimský P, Neumann FJ, Mauri L, Albertal M. Real-world safety and effectiveness outcomes of a zotarolimus-eluting stent: final 3-year report of the RESOLUTE International study. J Interv Cardiol. 2013 Oct; 26(5):515-23. PMID: 23980808; PMCID: PMC4238844.
  105. Lee M, Hiremath S, Zambahari R, Leon M, Mauri L, Yeung A. One-year outcomes of percutaneous coronary intervention with the 38-mm Resolute zotarolimus-eluting stent. Am J Cardiol. 2013 Nov 01; 112(9):1335-41. PMID: 23953695.
    View in: PubMed
  106. Wimmer NJ, Resnic FS, Mauri L, Matheny ME, Yeh RW. Comparison of transradial versus transfemoral percutaneous coronary intervention in routine practice: evidence for the importance of "falsification hypotheses" in observational studies of comparative effectiveness. J Am Coll Cardiol. 2013 Dec 03; 62(22):2147-8. PMID: 23954334.
    View in: PubMed
  107. Raccosta L, Fontana R, Maggioni D, Lanterna C, Villablanca EJ, Paniccia A, Musumeci A, Chiricozzi E, Trincavelli ML, Daniele S, Martini C, Gustafsson JA, Doglioni C, Feo SG, Leiva A, Ciampa MG, Mauri L, Sensi C, Prinetti A, Eberini I, Mora JR, Bordignon C, Steffensen KR, Sonnino S, Sozzani S, Traversari C, Russo V. The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils. J Exp Med. 2013 Aug 26; 210(9):1711-28. PMID: 23897983; PMCID: PMC3754872.
  108. Jacobs AK, Normand SL, Mauri L. PCI at hospitals with or without on-site cardiac surgery. N Engl J Med. 2013 Jul 25; 369(4):392-3. PMID: 23883385.
    View in: PubMed
  109. Vardi M, Burke DA, Bangalore S, Pencina MJ, Mauri L, Kandzari DE, Leon MB, Cutlip DE. Long-term efficacy and safety of Zotarolimus-eluting stent in patients with diabetes mellitus: pooled 5-year results from the ENDEAVOR III and IV trials. Catheter Cardiovasc Interv. 2013 Dec 01; 82(7):1031-8. PMID: 23737390.
    View in: PubMed
  110. Wasfy JH, Rosenfield K, Zelevinsky K, Sakhuja R, Lovett A, Spertus JA, Wimmer NJ, Mauri L, Normand SL, Yeh RW. A prediction model to identify patients at high risk for 30-day readmission after percutaneous coronary intervention. Circ Cardiovasc Qual Outcomes. 2013 Jul; 6(4):429-35. PMID: 23819957.
    View in: PubMed
  111. Wimmer NJ, Resnic FS, Mauri L, Matheny ME, Piemonte TC, Pomerantsev E, Ho KK, Robbins SL, Waldman HM, Yeh RW. Risk-treatment paradox in the selection of transradial access for percutaneous coronary intervention. J Am Heart Assoc. 2013 May 24; 2(3):e000174. PMID: 23709565; PMCID: PMC3698780.
  112. Mauri L, Foster E, Glower DD, Apruzzese P, Massaro JM, Herrmann HC, Hermiller J, Gray W, Wang A, Pedersen WR, Bajwa T, Lasala J, Low R, Grayburn P, Feldman T. 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J Am Coll Cardiol. 2013 Jul 23; 62(4):317-28. PMID: 23665364.
    View in: PubMed
  113. Kandzari DE, Leon MB, Meredith I, Fajadet J, Wijns W, Mauri L. Final 5-year outcomes from the Endeavor zotarolimus-eluting stent clinical trial program: comparison of safety and efficacy with first-generation drug-eluting and bare-metal stents. JACC Cardiovasc Interv. 2013 May; 6(5):504-12. PMID: 23602459.
    View in: PubMed
  114. Nathan A, Mauri L. Diabetic heart disease and interventional cardiology: how can clinical outcomes be improved? Revascularization guided by hemodynamic parameters (fractional flow reserve). Rev Esp Cardiol. 2013 Jun; 66(6):432-4. PMID: 23582732.
    View in: PubMed
  115. Nathan A, Mauri L. Diabetic heart disease and interventional cardiology: how can clinical outcomes be improved? Revascularization guided by hemodynamic parameters (fractional flow reserve). Rev Esp Cardiol (Engl Ed). 2013 Jun; 66(6):432-4. PMID: 24776044.
    View in: PubMed
  116. Kirtane AJ, Leon MB, Ball MW, Bajwa HS, Sketch MH, Coleman PS, Stoler RC, Papadakos S, Cutlip DE, Mauri L, Kandzari DE. The "final" 5-year follow-up from the ENDEAVOR IV trial comparing a zotarolimus-eluting stent with a paclitaxel-eluting stent. JACC Cardiovasc Interv. 2013 Apr; 6(4):325-33. PMID: 23523453.
    View in: PubMed
  117. Silber S, Serruys PW, Leon MB, Meredith IT, Windecker S, Neumann FJ, Belardi J, Widimsky P, Massaro J, Novack V, Yeung AC, Saito S, Mauri L. Clinical outcome of patients with and without diabetes mellitus after percutaneous coronary intervention with the resolute zotarolimus-eluting stent: 2-year results from the prospectively pooled analysis of the international global RESOLUTE program. JACC Cardiovasc Interv. 2013 Apr; 6(4):357-68. PMID: 23523454.
    View in: PubMed
  118. Gosev I, Nascimben L, Huang PH, Mauri L, Steigner M, Mizuguchi A, Shah AM, Aranki SF. Right ventricular perforation and pulmonary embolism with polymethylmethacrylate cement after percutaneous kyphoplasty. Circulation. 2013 Mar 19; 127(11):1251-3. PMID: 23509033.
    View in: PubMed
  119. Jacobs AK, Normand SL, Massaro JM, Cutlip DE, Carrozza JP, Marks AD, Murphy N, Romm IK, Biondolillo M, Mauri L. Nonemergency PCI at hospitals with or without on-site cardiac surgery. N Engl J Med. 2013 Apr 18; 368(16):1498-508. PMID: 23477625.
    View in: PubMed
  120. Farooq V, Vranckx P, Mauri L, Cutlip DE, Belardi J, Silber S, Widimsky P, Leon M, Windecker S, Meredith I, Negoita M, van Leeuwen F, Neumann FJ, Yeung AC, Garcia-Garcia HM, Serruys PW. Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE Program. Heart. 2013 May; 99(9):626-33. PMID: 23468513.
    View in: PubMed
  121. Sonnino S, Mauri L, Ciampa MG, Prinetti A. Gangliosides as regulators of cell signaling: ganglioside-protein interactions or ganglioside-driven membrane organization? J Neurochem. 2013 Feb; 124(4):432-5. PMID: 23351079.
    View in: PubMed
  122. Galper BZ, Mauri L. Antiplatelet therapy after coronary stenting. Curr Treat Options Cardiovasc Med. 2013 Feb; 15(1):1-10. PMID: 23263881.
    View in: PubMed
  123. Wimmer NJ, Yeh RW, Cutlip DE, Mauri L. Risk prediction for adverse events after carotid artery stenting in higher surgical risk patients. Stroke. 2012 Dec; 43(12):3218-24. PMID: 23127975.
    View in: PubMed
  124. Stolker JM, Cohen DJ, Kennedy KF, Pencina MJ, Lindsey JB, Mauri L, Cutlip DE, Kleiman NS. Repeat revascularization after contemporary percutaneous coronary intervention: an evaluation of staged, target lesion, and other unplanned revascularization procedures during the first year. Circ Cardiovasc Interv. 2012 Dec; 5(6):772-82. PMID: 23093553.
    View in: PubMed
  125. Valsecchi M, Mauri L, Casellato R, Ciampa MG, Rizza L, Bonina A, Bonina F, Sonnino S. Ceramides as possible nutraceutical compounds: characterization of the ceramides of the Moro blood orange ( Citrus sinensis ). J Agric Food Chem. 2012 Oct 10; 60(40):10103-10. PMID: 22985176.
    View in: PubMed
  126. Min JK, Leipsic J, Pencina MJ, Berman DS, Koo BK, van Mieghem C, Erglis A, Lin FY, Dunning AM, Apruzzese P, Budoff MJ, Cole JH, Jaffer FA, Leon MB, Malpeso J, Mancini GB, Park SJ, Schwartz RS, Shaw LJ, Mauri L. Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA. 2012 Sep 26; 308(12):1237-45. PMID: 22922562; PMCID: PMC4281479.
  127. Matteau A, Mauri L. Optimal timing of noncardiac surgery after stents. Circulation. 2012 Sep 11; 126(11):1322-4. PMID: 22965778.
    View in: PubMed
  128. Charytan DM, Garg P, Varma M, Garshick MS, Jeon C, Mauri L. Angiographic characteristics of coronary arterial segments progressing to myocardial infarction in patients with and without chronic kidney disease. Clin Exp Nephrol. 2013 Apr; 17(2):232-9. PMID: 22926696.
    View in: PubMed
  129. Camenzind E, Wijns W, Mauri L, Kurowski V, Parikh K, Gao R, Bode C, Greenwood JP, Boersma E, Vranckx P, McFadden E, Serruys PW, O'Neil WW, Jorissen B, Van Leeuwen F, Steg PG. Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial. Lancet. 2012 Oct 20; 380(9851):1396-405. PMID: 22951082.
    View in: PubMed
  130. Amin AP, Spertus JA, Cohen DJ, Chhatriwalla A, Kennedy KF, Vilain K, Salisbury AC, Venkitachalam L, Lai SM, Mauri L, Normand SL, Rumsfeld JS, Messenger JC, Yeh RW. Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice. Arch Intern Med. 2012 Aug 13; 172(15):1145-52. PMID: 22777536.
    View in: PubMed
  131. Brasile G, Mauri L, Sonnino S, Compostella F, Ronchetti F. A practical route to long-chain non-natural a,?-diamino acids. Amino Acids. 2013 Feb; 44(2):435-41. PMID: 22777284.
    View in: PubMed
  132. Stabile E, Garg P, Cremonesi A, Bosiers M, Reimers B, Setacci C, Cao P, Schmidt A, Sievert H, Peeters P, Nikas D, Werner M, de Donato G, Parlani G, Castriota F, Hornung M, Mauri L, Rubino P. European Registry of Carotid Artery Stenting: results from a prospective registry of eight high volume EUROPEAN institutions. Catheter Cardiovasc Interv. 2012 Aug 01; 80(2):329-34. PMID: 22556187.
    View in: PubMed
  133. Charytan DM, Stern NM, Mauri L. CKD and coronary collateral supply in individuals undergoing coronary angiography after myocardial infarction. Clin J Am Soc Nephrol. 2012 Jul; 7(7):1079-86. PMID: 22516292; PMCID: PMC3386673.
  134. Herrmann HC, Gertz ZM, Silvestry FE, Wiegers SE, Woo YJ, Hermiller J, Segar D, Heimansohn D, Gray W, Homma S, Argenziano M, Wang A, Jollis J, Lampert MB, Alexander J, Mauri L, Foster E, Glower D, Feldman T. Effects of atrial fibrillation on treatment of mitral regurgitation in the EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) randomized trial. J Am Coll Cardiol. 2012 Apr 03; 59(14):1312-9. PMID: 22464260.
    View in: PubMed
  135. Glower D, Ailawadi G, Argenziano M, Mack M, Trento A, Wang A, Lim DS, Gray W, Grayburn P, Dent J, Gillam L, Sethuraman B, Feldman T, Foster E, Mauri L, Kron I. EVEREST II randomized clinical trial: predictors of mitral valve replacement in de novo surgery or after the MitraClip procedure. J Thorac Cardiovasc Surg. 2012 Apr; 143(4 Suppl):S60-3. PMID: 22423604.
    View in: PubMed
  136. Mauri L. Why we still need randomized trials to compare effectiveness. N Engl J Med. 2012 Apr 19; 366(16):1538-40. PMID: 22452337.
    View in: PubMed
  137. Yeh RW, Rosenfield K, Zelevinsky K, Mauri L, Sakhuja R, Shivapour DM, Lovett A, Weiner BH, Jacobs AK, Normand SL. Sources of hospital variation in short-term readmission rates after percutaneous coronary intervention. Circ Cardiovasc Interv. 2012 Apr; 5(2):227-36. PMID: 22438431.
    View in: PubMed
  138. Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, Felberg R, Herrmann H, Kar S, Landzberg M, Raizner A, Wechsler L. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012 Mar 15; 366(11):991-9. PMID: 22417252.
    View in: PubMed
  139. Alli OO, Teirstein PS, Satler L, Sketch MH, Popma JJ, Mauri L, Wang HP, Schleckser PA, Cohen SA, Holmes DR. Five-year follow-up of the Sirolimus-Eluting Stents vs Vascular Brachytherapy for Bare Metal In-Stent Restenosis (SISR) trial. Am Heart J. 2012 Mar; 163(3):438-45. PMID: 22424015.
    View in: PubMed
  140. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2012 Feb 15; 79(3):453-95. PMID: 22328235.
    View in: PubMed
  141. Whitlow PL, Feldman T, Pedersen WR, Lim DS, Kipperman R, Smalling R, Bajwa T, Herrmann HC, Lasala J, Maddux JT, Tuzcu M, Kapadia S, Trento A, Siegel RJ, Foster E, Glower D, Mauri L, Kar S. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. J Am Coll Cardiol. 2012 Jan 10; 59(2):130-9. PMID: 22222076.
    View in: PubMed
  142. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011 Dec 06; 58(24):e44-122. PMID: 22070834.
    View in: PubMed
  143. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011 Dec 06; 124(23):2574-609. PMID: 22064598.
    View in: PubMed
  144. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011 Dec 06; 124(23):e574-651. PMID: 22064601.
    View in: PubMed
  145. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2013 Oct 01; 82(4):E266-355. PMID: 22065485.
    View in: PubMed
  146. Teixeira-Pinto A, Mauri L. Statistical analysis of noncommensurate multiple outcomes. Circ Cardiovasc Qual Outcomes. 2011 Nov 01; 4(6):650-6. PMID: 22085986.
    View in: PubMed
  147. Mauri L, Normand SL, Pencina M, Cutlip DE, Jeon C, Dreyer P, Kuntz RE, Baim DS, Jacobs AK. Rationale and design of the MASS COMM trial: A randomized trial to compare percutaneous coronary intervention between MASSachusetts hospitals with cardiac surgery on-site and COMMunity hospitals without cardiac surgery on-site. Am Heart J. 2011 Nov; 162(5):826-31. PMID: 22093197.
    View in: PubMed
  148. Yeh RW, Mauri L. Choosing methods to minimize confounding in observational studies: do the ends justify the means? Circ Cardiovasc Qual Outcomes. 2011 Nov 01; 4(6):581-3. PMID: 22085982.
    View in: PubMed
  149. Bangalore S, Cohen DJ, Kleiman NS, Regev-Beinart T, Rao SV, Pencina MJ, Mauri L. Bleeding risk comparing targeted low-dose heparin with bivalirudin in patients undergoing percutaneous coronary intervention: results from a propensity score-matched analysis of the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry. Circ Cardiovasc Interv. 2011 Oct 01; 4(5):463-73. PMID: 21972401.
    View in: PubMed
  150. Kandzari DE, Barker CS, Leon MB, Mauri L, Wijns W, Fajadet J, Mehran R. Dual antiplatelet therapy duration and clinical outcomes following treatment with zotarolimus-eluting stents. JACC Cardiovasc Interv. 2011 Oct; 4(10):1119-28. PMID: 22017938.
    View in: PubMed
  151. Mauri L, Casellato R, Ciampa MG, Uekusa Y, Kato K, Kaida K, Motoyama M, Kusunoki S, Sonnino S. Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a. Glycobiology. 2012 Mar; 22(3):352-60. PMID: 21921061.
    View in: PubMed
  152. Yeh RW, Normand SL, Wolf RE, Jones PG, Ho KK, Cohen DJ, Cutlip DE, Mauri L, Kugelmass AD, Amin AP, Spertus JA. Predicting the restenosis benefit of drug-eluting versus bare metal stents in percutaneous coronary intervention. Circulation. 2011 Oct 04; 124(14):1557-64. PMID: 21900079.
    View in: PubMed
  153. Min JK, Berman DS, Budoff MJ, Jaffer FA, Leipsic J, Leon MB, Mancini GB, Mauri L, Schwartz RS, Shaw LJ. Rationale and design of the DeFACTO (Determination of Fractional Flow Reserve by Anatomic Computed Tomographic AngiOgraphy) study. J Cardiovasc Comput Tomogr. 2011 Sep-Oct; 5(5):301-9. PMID: 21930103.
    View in: PubMed
  154. Lee MS, Park SJ, Kandzari DE, Kirtane AJ, Fearon WF, Brilakis ES, Vermeersch P, Kim YH, Waksman R, Mehilli J, Mauri L, Stone GW. Saphenous vein graft intervention. JACC Cardiovasc Interv. 2011 Aug; 4(8):831-43. PMID: 21851895.
    View in: PubMed
  155. Kandzari DE, Mauri L, Popma JJ, Turco MA, Gurbel PA, Fitzgerald PJ, Leon MB. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv. 2011 May; 4(5):543-50. PMID: 21596327.
    View in: PubMed
  156. Yeung AC, Leon MB, Jain A, Tolleson TR, Spriggs DJ, Mc Laurin BT, Popma JJ, Fitzgerald PJ, Cutlip DE, Massaro JM, Mauri L. Clinical evaluation of the Resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: the RESOLUTE US clinical trial. J Am Coll Cardiol. 2011 Apr 26; 57(17):1778-83. PMID: 21470813.
    View in: PubMed
  157. Feldman T, Foster E, Glower DD, Glower DG, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron E, Loghin C, Trento A, Skipper ER, Fudge T, Letsou GV, Massaro JM, Mauri L. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011 Apr 14; 364(15):1395-406. PMID: 21463154.
    View in: PubMed
  158. Mauri L, Leon MB, Yeung AC, Negoita M, Keyes MJ, Massaro JM. Rationale and design of the clinical evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the treatment of de novo lesions in native coronary arteries (the RESOLUTE US clinical trial). Am Heart J. 2011 May; 161(5):807-14. PMID: 21570508.
    View in: PubMed
  159. Sonnino S, Chigorno V, Aureli M, Masilamani AP, Valsecchi M, Loberto N, Prioni S, Mauri L, Prinetti A. Role of gangliosides and plasma membrane-associated sialidase in the process of cell membrane organization. Adv Exp Med Biol. 2011; 705:297-316. PMID: 21618114.
    View in: PubMed
  160. Prinetti A, Prioni S, Loberto N, Aureli M, Nocco V, Illuzzi G, Mauri L, Valsecchi M, Chigorno V, Sonnino S. Aberrant glycosphingolipid expression and membrane organization in tumor cells: consequences on tumor-host interactions. Adv Exp Med Biol. 2011; 705:643-67. PMID: 21618134.
    View in: PubMed
  161. Charytan DM, Varma MR, Silbaugh TS, Lovett AF, Normand SL, Mauri L. Long-term clinical outcomes following drug-eluting or bare-metal stent placement in patients with severely reduced GFR: Results of the Massachusetts Data Analysis Center (Mass-DAC) State Registry. Am J Kidney Dis. 2011 Feb; 57(2):202-11. PMID: 21186075.
    View in: PubMed
  162. Mauri L, Kereiakes DJ, Normand SL, Wiviott SD, Cohen DJ, Holmes DR, Bangalore S, Cutlip DE, Pencina M, Massaro JM. Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions. Am Heart J. 2010 Dec; 160(6):1035-41, 1041.e1. PMID: 21146655.
    View in: PubMed
  163. Mauri L, Massaro JM, Jiang S, Meredith I, Wijns W, Fajadet J, Kandzari DE, Leon MB, Cutlip DE, Thompson KP. Long-term clinical outcomes with zotarolimus-eluting versus bare-metal coronary stents. JACC Cardiovasc Interv. 2010 Dec; 3(12):1240-9. PMID: 21232717.
    View in: PubMed
  164. Garg P, Charytan DM, Novack L, Cutlip DE, Popma JJ, Moses J, Leon MB, Schofer J, Breithardt G, Schampaert E, Mauri L. Impact of moderate renal insufficiency on restenosis and adverse clinical events after sirolimus-eluting and bare metal stent implantation (from the SIRIUS trials). Am J Cardiol. 2010 Nov 15; 106(10):1436-42. PMID: 21059433.
    View in: PubMed
  165. Ormiston JA, Abizaid A, Spertus J, Fajadet J, Mauri L, Schofer J, Verheye S, Dens J, Thuesen L, Dubois C, Hoffmann R, Wijns W, Fitzgerald PJ, Popma JJ, Macours N, Cebrian A, Stoll HP, Rogers C, Spaulding C. Six-month results of the NEVO Res-Elution I (NEVO RES-I) trial: a randomized, multicenter comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions. Circ Cardiovasc Interv. 2010 Dec; 3(6):556-64. PMID: 21062998.
    View in: PubMed
  166. Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, Felberg R, Herrmann H, Kar S, Landzberg M, Raizner A, Wechsler L. Study design of the CLOSURE I Trial: a prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale. Stroke. 2010 Dec; 41(12):2872-83. PMID: 21051670.
    View in: PubMed
  167. Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Baldus S, Hauptmann KE, Suttorp MJ, Drzewiecki J, Pieper M, Schultheiss HP, Mauri L. Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study. EuroIntervention. 2010 Nov; 6(5):562-7. PMID: 21044908.
    View in: PubMed
  168. Leon MB, Nikolsky E, Cutlip DE, Mauri L, Liberman H, Wilson H, Patterson J, Moses J, Kandzari DE. Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial. JACC Cardiovasc Interv. 2010 Oct; 3(10):1043-50. PMID: 20965463.
    View in: PubMed
  169. Brown RA, Williams M, Barker CM, Mauri L, Meredith IT, Fajadet J, Wijns W, Leon MB, Kandzari DE. Sex-specific outcomes following revascularization with zotarolimus-eluting stents: comparison of angiographic and late-term clinical results. Catheter Cardiovasc Interv. 2010 Nov 15; 76(6):804-13. PMID: 20815043.
    View in: PubMed
  170. Novack V, Nguyen MC, Rooney M, Chacko R, Novack L, Pencina M, Apruzzese P, Mauri L, Cohen SA, Moses J, Leon MB, Cutlip DE. Effect of coronary target lesion revascularization on late cardiac events after insertion of sirolimus-eluting or bare metal stents. Am J Cardiol. 2010 Sep 15; 106(6):774-9. PMID: 20816116.
    View in: PubMed
  171. Stolker JM, Kennedy KF, Lindsey JB, Marso SP, Pencina MJ, Cutlip DE, Mauri L, Kleiman NS, Cohen DJ. Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry. Circ Cardiovasc Interv. 2010 Aug; 3(4):327-34. PMID: 20606136.
    View in: PubMed
  172. Jeon C, Candia SC, Wang JC, Holper EM, Ammerer M, Kuntz RE, Mauri L. Relative spatial distributions of coronary artery bypass graft insertion and acute thrombosis: a model for protection from acute myocardial infarction. Am Heart J. 2010 Jul; 160(1):195-201. PMID: 20598992.
    View in: PubMed
  173. Mauri L, Garg P, Massaro JM, Foster E, Glower D, Mehoudar P, Powell F, Komtebedde J, McDermott E, Feldman T. The EVEREST II Trial: design and rationale for a randomized study of the evalve mitraclip system compared with mitral valve surgery for mitral regurgitation. Am Heart J. 2010 Jul; 160(1):23-9. PMID: 20598968.
    View in: PubMed
  174. Garg P, Servoss SJ, Wu JC, Bajwa ZH, Selim MH, Dineen A, Kuntz RE, Cook EF, Mauri L. Lack of association between migraine headache and patent foramen ovale: results of a case-control study. Circulation. 2010 Mar 30; 121(12):1406-12. PMID: 20231534.
    View in: PubMed
  175. Valsecchi M, Aureli M, Mauri L, Illuzzi G, Chigorno V, Prinetti A, Sonnino S. Sphingolipidomics of A2780 human ovarian carcinoma cells treated with synthetic retinoids. J Lipid Res. 2010 Jul; 51(7):1832-40. PMID: 20194109; PMCID: PMC2882740.
  176. Naidu SS, Turco MA, Mauri L, Coolong A, Popma JJ, Kereiakes DJ. Contemporary incidence and predictors of major adverse cardiac events after saphenous vein graft intervention with embolic protection (an AMEthyst trial substudy). Am J Cardiol. 2010 Apr 15; 105(8):1060-4. PMID: 20381653.
    View in: PubMed
  177. Leon MB, Mauri L, Popma JJ, Cutlip DE, Nikolsky E, O'Shaughnessy C, Overlie PA, McLaurin BT, Solomon SL, Douglas JS, Ball MW, Caputo RP, Jain A, Tolleson TR, Reen BM, Kirtane AJ, Fitzgerald PJ, Thompson K, Kandzari DE. A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial. J Am Coll Cardiol. 2010 Feb 09; 55(6):543-54. PMID: 20152559.
    View in: PubMed
  178. Vasaiwala S, Forman DE, Mauri L. Drug-eluting stents in the elderly. Curr Treat Options Cardiovasc Med. 2010 Jan; 12(1):76-83. PMID: 20842483.
    View in: PubMed
  179. Sakhuja R, Mauri L. Controversies in the use of drug-eluting stents for acute myocardial infarction: a critical appraisal of the data. Annu Rev Med. 2010; 61:215-31. PMID: 20059336.
    View in: PubMed
  180. Bangalore S, Mauri L. Late loss in a disappearing frame of reference: is it still applicable to fully absorbable scaffolds? EuroIntervention. 2009 Dec 15; 5 Suppl F:F43-8. PMID: 22100675.
    View in: PubMed
  181. Leon MB, Kandzari DE, Eisenstein EL, Anstrom KJ, Mauri L, Cutlip DE, Nikolsky E, O'Shaughnessy C, Overlie PA, Kirtane AJ, McLaurin BT, Solomon SL, Douglas JS, Popma JJ. Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv. 2009 Dec; 2(12):1208-18. PMID: 20129547.
    View in: PubMed
  182. Camenzind E, Wijns W, Mauri L, Boersma E, Parikh K, Kurowski V, Gao R, Bode C, Greenwood JP, Gershlick A, O'Neill W, Serruys PW, Jorissen B, Steg PG. Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation. Am Heart J. 2009 Dec; 158(6):902-909.e5. PMID: 19958855.
    View in: PubMed
  183. Eisenstein EL, Leon MB, Kandzari DE, Mauri L, Edwards R, Kong DF, Cowper PA, Anstrom KJ. Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv. 2009 Dec; 2(12):1199-207. PMID: 20129546.
    View in: PubMed
  184. Eisenstein EL, Wijns W, Fajadet J, Mauri L, Edwards R, Cowper PA, Kong DF, Anstrom KJ. Long-term clinical and economic analysis of the Endeavor drug-eluting stent versus the Driver bare-metal stent: 4-year results from the ENDEAVOR II trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv. 2009 Dec; 2(12):1178-87. PMID: 20129543.
    View in: PubMed
  185. Lotan C, Meredith IT, Mauri L, Liu M, Rothman MT. Safety and effectiveness of the Endeavor zotarolimus-eluting stent in real-world clinical practice: 12-month data from the E-Five registry. JACC Cardiovasc Interv. 2009 Dec; 2(12):1227-35. PMID: 20129549.
    View in: PubMed
  186. Aureli M, Prioni S, Mauri L, Loberto N, Casellato R, Ciampa MG, Chigorno V, Prinetti A, Sonnino S. Photoactivable sphingosine as a tool to study membrane microenvironments in cultured cells. J Lipid Res. 2010 Apr; 51(4):798-808. PMID: 19820263; PMCID: PMC2842147.
  187. Kirtane AJ, Patel R, O'Shaughnessy C, Overlie P, McLaurin B, Solomon S, Mauri L, Fitzgerald P, Popma JJ, Kandzari DE, Leon MB. Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease. JACC Cardiovasc Interv. 2009 Oct; 2(10):967-76. PMID: 19850257.
    View in: PubMed
  188. Novack V, Cutlip D, Kleiman N, Pencina M, Mauri L, Yen CH, Berger P, Goldberg S, Kellett M, Waksman R, Hong M, Raizner AE, Cohen DJ. In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. JACC Cardiovasc Interv. 2009 Aug; 2(8):767-75. PMID: 19695546.
    View in: PubMed
  189. Schofer J, Siminiak T, Haude M, Herrman JP, Vainer J, Wu JC, Levy WC, Mauri L, Feldman T, Kwong RY, Kaye DM, Duffy SJ, Tübler T, Degen H, Brandt MC, Van Bibber R, Goldberg S, Reuter DG, Hoppe UC. Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation. 2009 Jul 28; 120(4):326-33. PMID: 19597051; PMCID: PMC3954526.
  190. Chacko R, Mulhearn M, Novack V, Novack L, Mauri L, Cohen SA, Moses J, Leon MB, Cutlip DE. Impact of target lesion and nontarget lesion cardiac events on 5-year clinical outcomes after sirolimus-eluting or bare-metal stenting. JACC Cardiovasc Interv. 2009 Jun; 2(6):498-503. PMID: 19539252.
    View in: PubMed
  191. Popma JJ, Mauri L, O'Shaughnessy C, Overlie P, McLaurin B, Almonacid A, Kirtane A, Leon MB. Frequency and clinical consequences associated with sidebranch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting coronary stents. Circ Cardiovasc Interv. 2009 Apr; 2(2):133-9. PMID: 20031706.
    View in: PubMed
  192. Dixon SR, Henriques JP, Mauri L, Sjauw K, Civitello A, Kar B, Loyalka P, Resnic FS, Teirstein P, Makkar R, Palacios IF, Collins M, Moses J, Benali K, O'Neill WW. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv. 2009 Feb; 2(2):91-6. PMID: 19463408.
    View in: PubMed
  193. Garg P, Normand SL, Silbaugh TS, Wolf RE, Zelevinsky K, Lovett A, Varma MR, Zhou Z, Mauri L. Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry. Circulation. 2008 Nov 25; 118(22):2277-85, 7p following 2285. PMID: 19001019.
    View in: PubMed
  194. Mauri L, Silbaugh TS, Wolf RE, Zelevinsky K, Lovett A, Zhou Z, Resnic FS, Normand SL. Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts. Circulation. 2008 Oct 28; 118(18):1817-27. PMID: 18852368; PMCID: PMC2821087.
  195. Mauri L, Silbaugh TS, Garg P, Wolf RE, Zelevinsky K, Lovett A, Varma MR, Zhou Z, Normand SL. Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med. 2008 Sep 25; 359(13):1330-42. PMID: 18815397.
    View in: PubMed
  196. Charytan DM, Kuntz RE, Garshick M, Candia S, Khan MF, Mauri L. Location of acute coronary artery thromboses in patients with and without chronic kidney disease. Kidney Int. 2009 Jan; 75(1):80-7. PMID: 18818684.
    View in: PubMed
  197. Holmes DR, Teirstein PS, Satler L, Sketch MH, Popma JJ, Mauri L, Wang HP, Schleckser PA, Cohen SA. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial. JACC Cardiovasc Interv. 2008 Aug; 1(4):439-48. PMID: 19463342.
    View in: PubMed
  198. Kereiakes DJ, Turco MA, Breall J, Farhat NZ, Feldman RL, McLaurin B, Popma JJ, Mauri L, Zimetbaum P, Massaro J, Cutlip DE. A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial. JACC Cardiovasc Interv. 2008 Jun; 1(3):248-57. PMID: 19463308.
    View in: PubMed
  199. Villablanca EJ, Zhou D, Valentinis B, Negro A, Raccosta L, Mauri L, Prinetti A, Sonnino S, Bordignon C, Traversari C, Russo V. Selected natural and synthetic retinoids impair CCR7- and CXCR4-dependent cell migration in vitro and in vivo. J Leukoc Biol. 2008 Sep; 84(3):871-9. PMID: 18515328.
    View in: PubMed
  200. Garg P, Cohen DJ, Gaziano T, Mauri L. Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic model. J Am Coll Cardiol. 2008 May 13; 51(19):1844-53. PMID: 18466798.
    View in: PubMed
  201. Mauri L, Normand SL. Studies of drug-eluting stents: to each his own? Circulation. 2008 Apr 22; 117(16):2047-50. PMID: 18427142.
    View in: PubMed
  202. Coolong A, Baim DS, Kuntz RE, O'Malley AJ, Marulkar S, Cutlip DE, Popma JJ, Mauri L. Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients. Circulation. 2008 Feb 12; 117(6):790-7. PMID: 18212287.
    View in: PubMed
  203. Mauri L, Silverstein T, Lovett A, Resnic FS, Normand S-LT. Long-term clinical outcomes following drug-eluting and bare metal stenting in Massachusetts. JAMA. 2008; Submitted.
  204. Garg P, Cohen DJ, Gaziano T, Mauri L. Balancing the risks of restenosis and stent thrombosis in bare metal vs. drug-eluting stents: Results of a decision analytic model. JACC. 2008; In press.
  205. Coolong A, Baim DS, Kuntz RE, O'Malley AJ, Marulkar S, Cutlip DE, Popma JJ, Mauri L. The risk of major adverse clinical events within 30 days of saphenous vein graft stenting: A predictive model derived from a pooled analysis of 3,958 patients. Circulation. 2008; In press.
  206. Nakayama H, Yoshizaki F, Prinetti A, Sonnino S, Mauri L, Takamori K, Ogawa H, Iwabuchi K. Lyn-coupled LacCer-enriched lipid rafts are required for CD11b/CD18-mediated neutrophil phagocytosis of nonopsonized microorganisms. J Leukoc Biol. 2008 Mar; 83(3):728-41. PMID: 18055569.
    View in: PubMed
  207. Iwabuchi K, Prinetti A, Sonnino S, Mauri L, Kobayashi T, Ishii K, Kaga N, Murayama K, Kurihara H, Nakayama H, Yoshizaki F, Takamori K, Ogawa H, Nagaoka I. Involvement of very long fatty acid-containing lactosylceramide in lactosylceramide-mediated superoxide generation and migration in neutrophils. Glycoconj J. 2008 May; 25(4):357-74. PMID: 18041581.
    View in: PubMed
  208. Prinetti A, Chigorno V, Mauri L, Loberto N, Sonnino S. Modulation of cell functions by glycosphingolipid metabolic remodeling in the plasma membrane. J Neurochem. 2007 Nov; 103 Suppl 1:113-25. PMID: 17986146.
    View in: PubMed
  209. Garg P, Mauri L. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation. Curr Opin Cardiol. 2007 Nov; 22(6):565-71. PMID: 17921745.
    View in: PubMed
  210. Kereiakes DJ, Mauri L, Kuntz RE. Letter by Kereiakes et al regarding article, "Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern". Circulation. 2007 Oct 16; 116(16):e389; author reply e390. PMID: 17938296.
    View in: PubMed
  211. Li YT, Li SC, Kiso M, Ishida H, Mauri L, Raimondi L, Bernardi A, Sonnino S. Effect of structural modifications of ganglioside GM2 on intra-molecular carbohydrate-to-carbohydrate interaction and enzymatic susceptibility. Biochim Biophys Acta. 2008 Mar; 1780(3):353-61. PMID: 17967427; PMCID: PMC2329919.
  212. Mauri L, Cox D, Hermiller J, Massaro J, Wahr J, Tay SW, Jonas M, Popma JJ, Pavliska J, Wahr D, Rogers C. The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial. J Am Coll Cardiol. 2007 Oct 09; 50(15):1442-9. PMID: 17919563.
    View in: PubMed
  213. Morice MC, Serruys PW, Barragan P, Bode C, Van Es GA, Stoll HP, Snead D, Mauri L, Cutlip DE, Sousa E. Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial. J Am Coll Cardiol. 2007 Oct 02; 50(14):1299-304. PMID: 17903626.
    View in: PubMed
  214. Campanero-Rhodes MA, Smith A, Chai W, Sonnino S, Mauri L, Childs RA, Zhang Y, Ewers H, Helenius A, Imberty A, Feizi T. N-glycolyl GM1 ganglioside as a receptor for simian virus 40. J Virol. 2007 Dec; 81(23):12846-58. PMID: 17855525; PMCID: PMC2169104.
  215. Hoffmann R, Morice MC, Moses JW, Fitzgerald PJ, Mauri L, Breithardt G, Schofer J, Serruys PW, Stoll HP, Leon MB. Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials. Heart. 2008 Mar; 94(3):322-8. PMID: 17761505.
    View in: PubMed
  216. Katzen BT, Criado FJ, Ramee SR, Massop DW, Hopkins LN, Donohoe D, Cohen SA, Mauri L. Carotid artery stenting with emboli protection surveillance study: thirty-day results of the CASES-PMS study. Catheter Cardiovasc Interv. 2007 Aug 01; 70(2):316-23. PMID: 17630678.
    View in: PubMed
  217. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007 May 01; 115(17):2344-51. PMID: 17470709.
    View in: PubMed
  218. Charytan D, Kuntz RE, Mauri L, DeFilippi C. Distribution of coronary artery disease and relation to mortality in asymptomatic hemodialysis patients. Am J Kidney Dis. 2007 Mar; 49(3):409-16. PMID: 17336702.
    View in: PubMed
  219. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007 Mar 08; 356(10):1020-9. PMID: 17296821.
    View in: PubMed
  220. Zou KH, O'Malley AJ, Mauri L. Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation. 2007 Feb 06; 115(5):654-7. PMID: 17283280.
    View in: PubMed
  221. Uchida T, Prpic R, Leon MB, Kuntz R, Mauri L. Treatment of isolated left anterior descending artery obstruction: Comparison of Sirolimus drug-eluting stenting with minimally invasive direct coronary bypass surgery. Am J Cardiol. 2007; Submitted.
  222. Kandzari DE, Leon MB, Popma JJ, Fitzgerald PJ, O'Shaughnessy C, Ball MW, Turco M, Applegate RJ, Gurbel PA, Midei MG, Badre SS, Mauri L, Thompson KP, LeNarz LA, Kuntz RE. Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial. J Am Coll Cardiol. 2006 Dec 19; 48(12):2440-7. PMID: 17174180.
    View in: PubMed
  223. Valsecchi M, Mauri L, Casellato R, Prioni S, Loberto N, Prinetti A, Chigorno V, Sonnino S. Ceramide and sphingomyelin species of fibroblasts and neurons in culture. J Lipid Res. 2007 Feb; 48(2):417-24. PMID: 17093290.
    View in: PubMed
  224. Sonnino S, Mauri L, Chigorno V, Prinetti A. Gangliosides as components of lipid membrane domains. Glycobiology. 2007 Jan; 17(1):1R-13R. PMID: 16982663.
    View in: PubMed
  225. Charytan D, Mauri L, Agarwal A, Servoss S, Scirica B, Kuntz RE. The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients. Am Heart J. 2006 Sep; 152(3):558-64. PMID: 16923431; PMCID: PMC4398776.
  226. Coolong A, Mauri L. Clopidogrel treatment surrounding percutaneous coronary intervention: when should it be started and stopped? Curr Cardiol Rep. 2006 Jul; 8(4):267-71. PMID: 16822362.
    View in: PubMed
  227. Mauri L, Rogers C, Baim DS. Devices for distal protection during percutaneous coronary revascularization. Circulation. 2006 Jun 06; 113(22):2651-6. PMID: 16754813.
    View in: PubMed
  228. Sonnino S, Prinetti A, Mauri L, Chigorno V, Tettamanti G. Dynamic and structural properties of sphingolipids as driving forces for the formation of membrane domains. Chem Rev. 2006 Jun; 106(6):2111-25. PMID: 16771445.
    View in: PubMed
  229. Baim DS, Mauri L, Cutlip DC. Drug-eluting stenting for unprotected left main coronary artery disease: are we ready to replace bypass surgery? J Am Coll Cardiol. 2006 Feb 21; 47(4):878-81. PMID: 16487859.
    View in: PubMed
  230. Mauri L, Kinlay S. Adjunctive devices. The Interventional Cardiologist. 2006; In press.
  231. Mauri L, Orav EJ, Candia SC, Cutlip DE, Kuntz RE. Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials. Circulation. 2005 Nov 01; 112(18):2833-9. PMID: 16267256.
    View in: PubMed
  232. Mauri L, Orav EJ, Kuntz RE. Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation. 2005 Jun 28; 111(25):3435-42. PMID: 15967844.
    View in: PubMed
  233. Mauri L, O'Malley AJ, Popma JJ, Moses JW, Leon MB, Holmes DR, Teirstein PS, Cutlip DE, Donahoe D, Kuntz RE. Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents. Am J Cardiol. 2005 May 15; 95(10):1140-5. PMID: 15877983.
    View in: PubMed
  234. Kereiakes DJ, Kuntz RE, Mauri L, Krucoff MW. Surrogates, substudies, and real clinical end points in trials of drug-eluting stents. J Am Coll Cardiol. 2005 Apr 19; 45(8):1206-12. PMID: 15837250.
    View in: PubMed
  235. Arosio D, Fontanella M, Baldini L, Mauri L, Bernardi A, Casnati A, Sansone F, Ungaro R. A synthetic divalent cholera toxin glycocalix[4]arene ligand having higher affinity than natural GM1 oligosaccharide. J Am Chem Soc. 2005 Mar 23; 127(11):3660-1. PMID: 15771476.
    View in: PubMed
  236. Mauri L, Orav EJ, O'Malley AJ, Moses JW, Leon MB, Holmes DR, Teirstein PS, Schofer J, Breithardt G, Cutlip DE, Kereiakes DJ, Shi C, Firth BG, Donohoe DJ, Kuntz RE. Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents. Circulation. 2005 Jan 25; 111(3):321-7. PMID: 15655127.
    View in: PubMed
  237. Wang JC, Normand SL, Mauri L, Kuntz RE. Coronary artery spatial distribution of acute myocardial infarction occlusions. Circulation. 2004 Jul 20; 110(3):278-84. PMID: 15249505.
    View in: PubMed
  238. Mauri L, O'Malley AJ, Cutlip DE, Ho KK, Popma JJ, Chauhan MS, Baim DS, Cohen DJ, Kuntz RE. Effects of stent length and lesion length on coronary restenosis. Am J Cardiol. 2004 Jun 01; 93(11):1340-6, A5. PMID: 15165911.
    View in: PubMed
  239. Prioni S, Mauri L, Loberto N, Casellato R, Chigorno V, Karagogeos D, Prinetti A, Sonnino S. Interactions between gangliosides and proteins in the exoplasmic leaflet of neuronal plasma membranes: a study performed with a tritium-labeled GM1 derivative containing a photoactivable group linked to the oligosaccharide chain. Glycoconj J. 2004; 21(8-9):461-70. PMID: 15750787.
    View in: PubMed
  240. Mauri L, Prioni S, Loberto N, Chigorno V, Prinetti A, Sonnino S. Synthesis of radioactive and photoactivable ganglioside derivatives for the study of ganglioside-protein interactions. Glycoconj J. 2004; 20(1):11-23. PMID: 14973366.
    View in: PubMed
  241. Kuntz RE, Wang JC, Mauri L, Cohen DJ. An evidence-based approach to the use of drug-eluting stents in clinical practice. Am Heart Hosp J. 2004; 2(3):132-41. PMID: 15805763.
    View in: PubMed
  242. Mauri L, O'Gara PT. Acute myocardial infarction. Conn's Current Therapy. 2004; 380-4.
  243. Mauri L, Valsecchi M, Casellato R, Li SC, Li YT, Sonnino S. Procedure for separation of GM2 ganglioside species with different ceramide structures by a flash reversed-phase silica gel liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Oct 25; 796(1):1-10. PMID: 14552811.
    View in: PubMed
  244. Mauri L, Reisman M, Buchbinder M, Popma JJ, Sharma SK, Cutlip DE, Ho KK, Prpic R, Zimetbaum PJ, Kuntz RE. Comparison of rotational atherectomy with conventional balloon angioplasty in the prevention of restenosis of small coronary arteries: results of the Dilatation vs Ablation Revascularization Trial Targeting Restenosis (DART). Am Heart J. 2003 May; 145(5):847-54. PMID: 12766743.
    View in: PubMed
  245. Mauri L, Bonan R, Weiner BH, Legrand V, Bassand JP, Popma JJ, Niemyski P, Prpic R, Ho KK, Chauhan MS, Cutlip DE, Bertrand OF, Kuntz RE. Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized Trial. Am J Cardiol. 2002 Nov 15; 90(10):1079-83. PMID: 12423707.
    View in: PubMed
  246. Rizzo AM, Berra B, Rossi F, Guerra A, Gornati R, Bernardini G, Taki T, Kasama T, Mauri L, Sonnino S. Structure of the main ganglioside from the brain of Xenopus laevis. Glycoconj J. 2002 Jan; 19(1):53-7. PMID: 12652080.
    View in: PubMed
  247. Mauri L, de Lemos JA, O'Gara PT. Infective endocarditis. Curr Probl Cardiol. 2001 Sep; 26(9):562-610. PMID: 11584248.
    View in: PubMed
  248. Valiente O, Mauri L, Casellato R, Fernandez LE, Sonnino S. Preparation of deacetyl-, lyso-, and deacetyl-lyso-GM(3) by selective alkaline hydrolysis of GM3 ganglioside. J Lipid Res. 2001 Aug; 42(8):1318-24. PMID: 11483634.
    View in: PubMed
  249. Mauri L, O'Gara PT. Valvular Heart Disease in the Pregnant Patient. Curr Treat Options Cardiovasc Med. 2001 Feb; 3(1):7-14. PMID: 11139785.
    View in: PubMed
  250. Vignati G, Balla E, Mauri L, Lunati M, Figini A. Clinical and electrophysiologic evolution of the Wolff-Parkinson-White syndrome in children: impact on approaches to management. Cardiol Young. 2000 Oct; 10(4):367-75. PMID: 10950334.
    View in: PubMed
  251. García-Cardeña G, Anderson KR, Mauri L, Gimbrone MA. Distinct mechanical stimuli differentially regulate the PI3K/Akt survival pathway in endothelial cells. Ann N Y Acad Sci. 2000 May; 902:294-7. PMID: 10865850.
    View in: PubMed
  252. Prinetti A, Marano N, Prioni S, Chigorno V, Mauri L, Casellato R, Tettamanti G, Sonnino S. Association of Src-family protein tyrosine kinases with sphingolipids in rat cerebellar granule cells differentiated in culture. Glycoconj J. 2000 Mar-Apr; 17(3 -4):223-32. PMID: 11201794.
    View in: PubMed
  253. Vignati G, Brucato A, Pisoni MP, Pomè G, La Placa S, Mauri L, Lunati M. [Clinical course of pre- and post-natal isolated congenital atrioventricular block diagnosed in utero]. G Ital Cardiol. 1999 Dec; 29(12):1478-87. PMID: 10687111.
    View in: PubMed
  254. Danzi GB, Capuano C, Fiocca L, Dallavalle F, Pirelli S, Mauri L, Quaini E. Stent implantation without predilation in patients with a single, noncalcified coronary artery lesion. Am J Cardiol. 1999 Nov 15; 84(10):1250-3, A8. PMID: 10569338.
    View in: PubMed
  255. Danzi GB, Fiocca L, Capuano C, Mauri L, Dallavalle F, Quaini E. [Direct stenting of the unprotected common trunk in patients at an elevated surgical risk; the authors' personal experience and a review of the literature]. G Ital Cardiol. 1999 May; 29(5):568-74. PMID: 10367227.
    View in: PubMed
  256. Mauri L, Casellato R, Kirschner G, Sonnino S. A procedure for the preparation of GM3 ganglioside from GM1-lactone. Glycoconj J. 1999 Mar; 16(3):197-203. PMID: 10596894.
    View in: PubMed
  257. Hajjar KA, Mauri L, Jacovina AT, Zhong F, Mirza UA, Padovan JC, Chait BT. Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine. J Biol Chem. 1998 Apr 17; 273(16):9987-93. PMID: 9545344.
    View in: PubMed
  258. Danzi GB, Pirelli S, Mauri L, Testa R, Ciliberto GR, Massa D, Lotto AA, Campolo L, Parodi O. Which variable of stenosis severity best describes the significance of an isolated left anterior descending coronary artery lesion? Correlation between quantitative coronary angiography, intracoronary Doppler measurements and high dose dipyridamole echocardiography. J Am Coll Cardiol. 1998 Mar 01; 31(3):526-33. PMID: 9502630.
    View in: PubMed
  259. Vignati G, Drago F, Mauri L, Guccione P, Ragonese P, Figini A. [Idiopathic recurrent ventricular tachycardia in children: characteristics and long-term prognosis]. G Ital Cardiol. 1996 Jul; 26(7):747-55. PMID: 8964317.
    View in: PubMed
  260. Vignati G, Mauri L, Figini A. The use of propafenone in the treatment of tachyarrhythmias in children. Eur Heart J. 1993 Apr; 14(4):546-50. PMID: 8472721.
    View in: PubMed
  261. Danzi GB, Mauri L, Formentini A, Pirelli S, Campolo L. [The PTCA of venous grafts: the immediate and long-term results]. G Ital Cardiol. 1992 Nov; 22(11):1285-91. PMID: 1297614.
    View in: PubMed
  262. Vignati G, Mauri L, Lunati M, Gasparini M, Figini A. Transoesophageal electrophysiological evaluation of paediatric patients with Wolff-Parkinson-White syndrome. Eur Heart J. 1992 Feb; 13(2):220-2. PMID: 1555620.
    View in: PubMed
  263. Arboix A, Mauri L, Martí-Vilalta JL. [Affective disorders in subcortical ischemic cerebrovascular pathology. Prospective clinical study of 43 patients]. Med Clin (Barc). 1990 Mar 03; 94(8):281-5. PMID: 2342388.
    View in: PubMed
  264. Ciliberto GR, Cataldo G, Cipriani M, Mascarello M, Faletra F, Gronda E, De Maria R, Mauri L, Pezzano A. Echocardiographic assessment of cardiac allograft rejection. Eur Heart J. 1989 May; 10(5):400-8. PMID: 2668002.
    View in: PubMed
  265. Carù B, Mauri L, Andreuzzi B, Azzollini M, Cupellini GP. Arrhythmias in sport. Eur Heart J. 1987 Aug; 8 Suppl D:47-50. PMID: 3678261.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Mauri's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_